Back to results

Massachusetts Institute of Technology

Microcapsule drug delivery device for treatment of glioblastoma multiforme

Abstract

dc:description.abstract

Controlled-release drug delivery systems are capable of treating debilitating diseases, including cancer. Brain cancer, in particular glioblastoma multiforme (GBM), is an extremely invasive cancer with a dismal prognosis. The use of drugs capable of crossing the blood-brain barrier has shown modest prolongation in patient survival, but not without unsatisfactory systemic, dose-limiting toxicity. Localized delivery of potent chemotherapeutics aims to lower systemic toxicity while increasing drug concentrations directly to the tumor site. I have developed implantable drug delivery microcapsule devices for the localized delivery of temozolomide and for treatment of glioblastoma multiforme in this work. I have been able to modulate the drug release profiles from these microcapsules based on the physical chemistry of the drug and the dimensions of the release orifices in these devices. Experimental in vitro studies were performed in order to test the function, reliability, and drug release kinetics of the devices. The experimental release curves showed mass flow rates of 36 ug/hr for single-orifice devices and an 88 ug/hr mass flow rate for multiple-orifice devices loaded with temozolomide. Intracranial temozolomide-filled microcapsules were tested in a rodent 9L glioma model. Outcomes were animal survival and immunohistochemical analysis of tissue for evidence of DNA strand breaks via terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. Results showed that localized delivery of chemotherapeutics from microcapsule devices is capable of prolonging animal survival and may offer an alternative to the harsh side-effects and low response rates inherent to systemic drug administration in GBM patients.

Degree

thesis:*
Department dc:contributor.department
Massachusetts Institute of Technology. Dept. of Materials Science and Engineering.
Grantor dc:publisher
Massachusetts Institute of Technology
Year dc:date.issued
2010

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Scott, Alexander Wesley
Advisor dc:contributor.advisor
  • Michael J. Cima and Robert S. Langer.

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.
Language dc:language.iso
eng

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1721.1/59246
OAI identifier oai:identifier
oai:dspace.mit.edu:1721.1/59246

Chain of custody

source
Harvested from
MIT
Base URL
dspace.mit.edu/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
citation

Scott, Alexander Wesley. Microcapsule drug delivery device for treatment of glioblastoma multiforme. Massachusetts Institute of Technology, 2010. http://hdl.handle.net/1721.1/59246